AstraZeneca shares dropped Tuesday after a report that dozens of the company’s senior executives in China potentially have ...

AstraZeneca shares recorded their biggest one-day drop since March 2020 on Tuesday following a report that dozens of senior ...

An insurance fraud investigation linked to AstraZeneca (AZN) expands in China involving dozens of senior executives. Read ...

AstraZeneca Plc shares plunged in London, erasing about £14 billion ($18 billion) of market value, amid escalating concerns ...

AstraZeneca's (NASDAQ:AZN) selloff on Tuesday in response to reports that the company is facing a fraud investigation in ...

AstraZeneca suffered a £14bn share price hit on Tuesday after Chinese media reported more details about an investigation into ...

AstraZeneca’s stock price dropped by 8.4% during Tuesday’s trading in London after a report fueled fears of a potentially ...

Shares of AstraZeneca (AZN) are lower as more headlines emerge on the scope of the ongoing China probe of the company’s China president, ...

BofA notes that AstraZeneca (AZN) shares are down greater than 10% in the last few days on the back of China concerns around the ongoing ...

Chinese authorities detained AstraZeneca employees amid a probe into data privacy breaches and unlicensed drug sales, stock ...

AstraZeneca shares fell 8% in London Tuesday, the biggest drop in four years following a fresh report that a Chinese investigation of the company has widened. AstraZeneca said last week that its China ...

AstraZeneca's shares have fallen more than 8% on speculation about an anti-corruption probe in China, its second-largest ...